Opioid and neuroHIV Comorbidity - Current and Future Perspectives.

Fitting, Sylvia; McRae, MaryPeace; Hauser, Kurt F

Fitting, Sylvia; McRae, MaryPeace; Hauser, Kurt F.

Afiliación

Fitting S; Department of Psychology and Neuroscience, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599-3270, USA.
McRae M; Department of Pharmacotherapy and Outcomes Science, School of Pharmacy, Virginia Commonwealth University, Richmond, VA, 23298, USA.
Hauser KF; Department of Pharmacology and Toxicology, School of Medicine, Virginia Commonwealth University, 1217 East Marshall Street, Richmond, VA, 23298-0613, USA. kurt.hauser@vcuhealth.org.

J Neuroimmune Pharmacol ; 15(4): 584-627, 2020 12.

Article en En | MEDLINE | ID: mdl-32876803

Asunto(s)

Complejo SIDA Demencia/complicaciones; COVID-19; Infecciones por VIH/complicaciones; Epidemia de Opioides; Trastornos Relacionados con Opioides/epidemiología; VIH-1/inmunología; Humanos

Palabras clave

Antiretroviral therapy; Astrocyte; Blood-brain barrier; Buprenorphine; C-C motif chemokine receptor 5 (CCR5); COVID-19; Cytochrome P450 3A4 (CYP 3A4); Endogenous opioid system of peptides and receptors; Functional selectivity/biased agonism; HIV-associated neurocognitive disorders; Maladaptive neuroplasticity; Methadone; Microglia; Oligodendroglia; P-glycoprotein; Pro-brain-derived neurotrophic factor (pro-BDNF); Synaptodendritic degeneration; neuroHIV; µ-Opioid receptor (OPRM1)

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Infecciones por VIH / Complejo SIDA Demencia / Epidemia de Opioides / COVID-19 / Trastornos Relacionados con Opioides Tipo de estudio: Prognostic_studies Idioma: En Revista: J Neuroimmune Pharmacol Asunto de la revista: ALERGIA E IMUNOLOGIA / FARMACOLOGIA / NEUROLOGIA Año: 2020 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google